PD-L1 anticorps (FITC)
Aperçu rapide pour PD-L1 anticorps (FITC) (ABIN7648460)
Antigène
Voir toutes PD-L1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- FITC-Linked Anti-Programmed Cell Death Protein 1 Ligand 1 (PDL1) Monoclonal Antibody
-
Purification
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Western blotting: 0.2-2 μg/mL,1:500-5000 Immunohistochemistry: 5-20 μg/mL,1:50-200 Immunocytochemistry: 5-20 μg/mL,1:50-200 Optimal working dilutions must be determined by end user.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 4°C, protected from prolonged exposure to light.
-
-
- PD-L1 (CD274 (PD-L1))
-
Autre désignation
- Programmed Cell Death Protein 1 Ligand 1
-
Sujet
- CD274, PDCD1LG1, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1-LG1, Programed Death Ligand 1
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Antigène
-